期刊文献+

脑源性神经营养因子在阻塞性呼吸睡眠暂停综合征患者血清中的表达及临床意义 被引量:2

Expression of brain-derived neurotrophic factor in serum of patients with obstructive sleep apnea-hypopnea syndrome and its clinical value
原文传递
导出
摘要 目的探讨脑源性神经营养因子(BDNF)在阻塞性呼吸睡眠暂停综合征(OSAHS)患者血清中的表达状况及临床意义。方法 20名健康对照者及42名OSAHS患者纳入研究。根据呼吸暂停低通气指数(AHI)将患者分为轻度OSAHS组(n=12)、中度OSAHS组(n=19)与重度OSAHS组(n=11)。记录患者的AHI、嗜睡量表评分(ESS)、最低氧饱和度(LSaO2)。采用酶联免疫吸附试验(ELISA)法检测所有被研究者血清中的BDNF水平。结果相比健康对照组,OSAHS组血清中BDNF水平明显升高(P<0.01),OSAHS越重,血清中BDNF越高(P<0.01);血清中BDNF水平随AHI指数的增加而升高,呈显著正相关(r=0.815);与ESS亦呈正相关(r=0.631),与LSaO2呈负相关(r=-0.723)。结论 BDNF在OSAHS患者中显著上升,与AHI、ESS呈正相关,与LSaO2呈负相关;BDNF可以作为OSAHS的重要预测指标。 [ Objective ] To investigate the expression status of brain-derived neurotrophic factor ( BDNF ) in serum of patients with obstructive sleep apnea-hypopnea syndrome (OSAHS) and its clinical value. [ Methods ] 20 normal controls and 42 OSAHS patients were enrolled in this study. According to the apnea hypopnea index ( AHI ) , patients were divided into 3 groups : mild OSAHS group ( n = 12 ), moderate OSAHS group ( n = 19 ) and severe OSAHS group ( n = 11 ). AHI, Epworth sleepiness scale ( ESS ) scores and the lowest oxygen saturation ( LSaO2) of patients were recorded. The levels of serum BDNF were measured by ELISA. [ Results ] Compared with the normal control group, the levels of serum BDNF in OSAHS groups increased significantly ( P 〈0. 01), and the serum BDNF level elevated with the severity of OSAHS ( P 〈 0.01 ). Linear correlation analysis suggested that serum BDNF levels were positively correlated with the AHI ( r = 0. 815 ) and ESS ( r = 0.631 ), but negatively correlated with the LSaO2 (r = -0. 723). [ Conclusion] The serum BDNF levels in OSAHS patients increase significantly, which are positively cor- related with AHI and ESS, but negatively correlated with the LSaO2. So BDNF can be used as an important predictor of OSAHS.
作者 陈静 江洪
出处 《职业与健康》 CAS 2013年第23期3212-3213,3216,共3页 Occupation and Health
基金 国家青年科学基金项目(项目编号:国家级81200156)
关键词 阻塞性呼吸睡眠暂停综合征 血清脑源性神经营养因子 呼吸暂停低通气指数 嗜睡量表评分 最低氧饱和度 Obstructive sleep apnea-hypopnea syndrome ( OSAHS) Serum brain-derived neurotrophic factor ( BDNF) Apnea hy- popnea index (AHI) Epworth sleepiness scale ( ESS) Lowest oxygen saturation ( LSaO2)
  • 相关文献

参考文献13

  • 1Olson EJ, Moore WR, Morgenthaler TI, et al. Obstructive sleep apnea-hypopnea syndrome[ J]. Mayo Clin Proc, 2003,78:1545 - 1552.
  • 2Parish JM, Somers VK. Obstructive sleep apnea and cardiovascular dis-ease [J]. Mayo Clin Proc, 2004, 79: 1036 - 1046.
  • 3Joo EY, Tae WS, Lee MJ, et al. Reduced brain gray matter concentra-tion in patients with obstructive sleep apnea syndrome [ J ] . Sleep, 2010,33:235 -241.
  • 4Patil SP, Schneider H, Schwartz AR, et al. Adult obstructive sleep ap-nea: pathophysiology and diagnosis[ J]. Chest,2007,132:325 -337.
  • 5Lindsay RM, Barde YA, Davies AM, et al. Differences and similaritiesin the neurotrophic growth factor requirements of sensory neurons derivedfrom neural crest and neural placode [ J ]. J Cell Sci Suppl, 1985,3:115-129.
  • 6Weishaupt N, Blesch A, Fouad K. BDNF: the career of a multifacetedneurotrophin in spinal cord injury [ J ]. Exp Neurol, 2012,238:254-264.
  • 7Kermani P, Hempstead B. Brain-derived neurotrophic factor: a newlydescribed mediator of angiogenesis[ J]. Trends Cardiovasc Med,2007,17:140-143.
  • 8Epstein LJ,Kristo D,Strollo PJ,et al. Clinical guideline foy the evalua-tion ,management alld lvng-term Care of obstructive sleep apnea in adults[J]. J Clin Sleep Med,2009,5:263 -276.
  • 9Fleetham J, Ayas N, Bradley D, et al. Canadian Thoracic Society 2011guideline update : diagnosis and treatment of sleep disordered breathing[J].Can Respir J, 2011, 18:25 -47.
  • 10Duran J, Esnaola S, Rubio R, et al. Obstructive sleep apnea-hypopneaand related clinical features in a population-based sample of subjectsaged 30 to 70 yr [ J ]. Am J Respir Crit Care Med,2001,163:685 -689.

同被引文献30

  • 1张希龙.睡眠呼吸暂停综合征与糖尿病及代谢综合征[J].中国实用内科杂志,2007,27(16):1261-1263. 被引量:13
  • 2Fava C,Montagnana M,Favaloro EJ,et al.Obstructive sleep apnea syndrome and cardiovascular diseases[J].Semin Thromb Hemost,2011,37(3):280-297.
  • 3Freet CS,Stoner JF,Tang X.Baroreflex and chemoreflex controls of sympathetic activity following intermittent hypoxia[J].Auton Neurosci,2013,174(1-2):8-14.
  • 4Franco CM,Lima AM,Ataide L,et al.Obstructive sleep apnea severity correlates with cellular and plasma oxidative stress parameters and affective symptoms[J].J Mol Neurosci,2012,47(2):300-310.
  • 5Su MC,Chen YC,Huang KT,et al.Association of metabolic factors with high sensitivity C-reactive protein in patients with sleep-disordered breathing[J].Eur Arch Otorhinolaryngol,2013,270(2):749-754.
  • 6Uzkeser H,Yildirim K,Aktan B,et al.Bone mineral density in patients with obstructive sleep apnea syndrome[J].Sleep Breath,2013,17(1):339-342.
  • 7Bataille C,Mauprivez C,HaE,et al.Different sympathetic pathways control the metabolism of distinct bone envelopes[J].Bone,2012,50(5):1162-1172.
  • 8Driessler F,Baldock PA.Hypothalamic regulation of bone[J].J Mol Endocrinol,2010,45(4):175-181.
  • 9Svensson M,Venge P.Janso sleep-disordered breathing inflammation in women from the general population[J].J Sleep Res,2012,21(2):147-154.
  • 10Lam JC,Mak JC,Ip MS.Obesity,obstructive sleep apnoea and metabolic syndrome[J].Respirology,2012,17(2):223-236.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部